MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0065336
Nissor Pharmaceuticals Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.2 Cr
▼ 52% YoY
Net loss · FY 2025
₹13.06 Lakh
Net margin -10.9%
EBITDA · FY 2025
-₹6.24 Lakh
EBITDA margin -5.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹60 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
4
As per MCA filings
About Nissor Pharmaceuticals Limited
Data last updated:
Nissor Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2015PLC264184. Its GSTIN is 27AAECN9213F1ZI (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Manish Pitambar Satia and Berkha Pitamber Satia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 8 Ground Floor Plot 40 Shilpin Centre G. D. Ambekar Marg Wadala, Mumbai, Maharashtra, India – 400031.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.2 Cr, a decline of 52% compared to the previous year. For the same year it recorded a net loss of ₹13.06 Lakh (net margin -10.9%) and EBITDA of -₹6.24 Lakh (EBITDA margin -5.2%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 31% over five years.
The company is associated with 1 brand: Nissor Pharmaceuticals. As per MCA filings, the company has open charges of ₹60 Lakh on record. The company has 1 deal on record (1 secondary share transfer); the latest was in November 2021.
Nissor Pharmaceuticals Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0065336). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nissor.com.
Company details
CIN U74900MH2015PLC264184
Registration Number 264184
Incorporation Date 08 May 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0065336
Key People
Manish Pitambar Satia Director Berkha Pitamber Satia Director Vansh Hasmukh Jain Director Recognitions & Rankings of Nissor Pharmaceuticals
Contact details
Nissor Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is nissor.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressShop No. 8 Ground Floor Plot 40 Shilpin Centre G. D. Ambekar Marg Wadala, Mumbai, Maharashtra, India – 400031
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nissor Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Nissor Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nissor Pharmaceuticals operates one associated brand: Nissor Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Research and development in bio-therapeutics, cosmetology, and herbal products in India. | nissor.com |
Business activity
The main business activity of Nissor Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Nissor Pharmaceuticals Limited, buy the company report.
Financials of Nissor Pharmaceuticals Limited
FY 2025 filings availableNissor Pharmaceuticals Limited reported revenue of ₹1.2 Cr (down 52% YoY) for FY 2025.
Revenue · FY 2025
₹1.2 Cr ▼ 52%
Net loss · FY 2025
₹13.06 Lakh margin -10.9%
EBITDA · FY 2025
-₹6.24 Lakh margin -5.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 52%
3 years · compounded
▼ 19%
5 years · compounded
▼ 31%
EBITDA CAGR growth
1 year
▲ 48%
3 years · compounded
▼ 30%
5 years · compounded
▼ 17%
Revenue has declined at a compounded annual rate (CAGR) of 31% over five years, including a 52% fall in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.06 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.2% | ||||
| Net Profit Margin | -10.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nissor Pharmaceuticals Limited, buy the company report.
Board of directors of Nissor Pharmaceuticals Limited
Nissor Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Pitambar Satia Also directs: Just Creativo Private Limited, Nexus Lifecare Private Limited | Director | 08 May 2015 | 11 Years 5 Months | Current |
| Berkha Pitamber Satia | Director | 10 Aug 2020 | 6 Years 2 Months | Current |
| Vansh Hasmukh Jain | Director | 01 Mar 2019 | 7 Years 7 Months | Current |
| Jeet Jain Champalal Also directs: Just Creativo Private Limited, Nexus Lifecare Private Limited | Director | 08 May 2015 | 11 Years 5 Months | Current |
Auditor
Nissor Pharmaceuticals Limited is audited by V K DUGAR & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V K DUGAR & ASSOCIATES | FY 2021 | 130769W |
Shareholding
The shareholding of Nissor Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nissor Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹60 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2018 | 100241616 | Others | ₹60 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Nissor Pharmaceuticals Limited has 1 deal on record (1 secondary share transfer); the latest was in November 2021.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Nissor Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nissor Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nissor Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECN9213F1ZI | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nissor Pharmaceuticals Limited, buy the company report.
Recent activity
Nissor Pharmaceuticals Limited has 8 board changes on record since 2015: 4 appointments and 4 cessations. The latest: Berkha Pitamber Satia ceased to be Additional Director on 31 Dec 2020.
AGM
Nissor Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nissor Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Berkha Pitamber Satia ceased to be Additional Director.
Appointed
Berkha Pitamber Satia was appointed as Director.
Ceased
Pitambar Thakurdas Satia ceased to be Director.
Ceased
Vansh Hasmukh Jain ceased to be Additional Director.
Appointed
Vansh Hasmukh Jain was appointed as Director.
Ceased
Hasmukh Jain Champalal ceased to be Director.
Charges
A charge with Others amounted to Rs. 60.00 Lakh with Charge ID 100241616 was registered on 29 Sep 2018.
Appointed
Jeet Jain Champalal was appointed as Director.
Appointed
Manish Pitambar Satia was appointed as Director.
Incorporation
08 May 2015
Nissor Pharmaceuticals Limited was registered on 08 May 2015 with Roc Mumbai & aged 11 years 5 months as per MCA records.
Frequently asked questions
Nissor Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 May 2015 (11+ years old) and is registered under CIN U74900MH2015PLC264184.
Nissor Pharmaceuticals has 4 current directors:
- Manish Pitambar Satia - Director
- Berkha Pitamber Satia - Director
- Vansh Hasmukh Jain - Director
- Jeet Jain Champalal - Director
The latest financial statements of Nissor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Nissor Pharmaceuticals is 27AAECN9213F1ZI, registered in Maharashtra.
The CIN (Corporate Identification Number) of Nissor Pharmaceuticals is U74900MH2015PLC264184. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nissor Pharmaceuticals was incorporated on 08 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Nissor Pharmaceuticals has 1 deal on record (1 secondary share transfer); the latest was in November 2021.
Berkha Pitamber Satia ceased to be Additional Director on 31 Dec 2020. Berkha Pitamber Satia was appointed as Director on 10 Aug 2020. Pitambar Thakurdas Satia ceased to be Director on 27 Jan 2020. Nissor Pharmaceuticals has 8 board changes on record in total.
Yes, Nissor Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0065336).
Nissor Pharmaceuticals can be reached through the website nissor.com. Its registered office is in Mumbai, Maharashtra, India.